Franca Formelli

Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells

Valentina Zuco, Rosanna Supino, Sabina Carla Righetti et al. · Cancer Letters · 2002 · 521 citations

Tumor Biology, Oncogenic Agent, Medicine +9

Randomized Trial of Fenretinide to Prevent Second Breast Malignancy in Women With Early Breast Cancer

Umberto Veronesi, G. De Palo, Ettore Marubini et al. · JNCI Journal of the National Cancer Institute · 1999 · 421 citations · Full text

In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor

Philipp le Coutre, Luca Mologni, Loredana Cleris et al. · JNCI Journal of the National Cancer Institute · 1999 · 377 citations · Full text

<i>In vitro</i> and <i>In vivo</i> Activity of SKI-606, a Novel Src-Abl Inhibitor, against Imatinib-Resistant Bcr-Abl+ Neoplastic Cells

Miriam Puttini, Addolorata Maria Luce Coluccia, Frank Boschelli et al. · Cancer Research · 2006 · 368 citations

Hematological Malignancy, Cell Signaling, Ski-606 Activity +13

N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.

Domenico Delia, Antonella Aiello, Luciano Lombardi et al. · PubMed · 1993 · 248 citations

Chemoprevention Strategy, Retinamide Induces Apoptosis, Retinoic Acid Receptor +18